Ravindra Kumar

Dr. Ravindra Kumar is an accomplished professional with a combined experience of 18 years in academia and biopharmaceutical industry. He received his Ph.D. in molecular biology and immunology from JNU, India in collaboration with Uppsala University, Sweden. Dr. Kumar has extensive experience in biologic, vaccine, and gene therapy analytics of early to commercial phase programs. He has led multiple complex projects and cross-functional groups, mentored scientists, provided technical oversight, analyzed complex data, and published research articles in peer-reviewed high impact journals. In his current role at Spark Therapeutics, he serves as a bioassay subject matter expert and leads a group of scientists to support bioassays for early to commercial gene therapy products.